F-group (family)
2004.1.1.45 MutS_V
Ligands and drugs
1,107
Member domains
110
with ligand contacts (≤ 4 Å)
9.9% of members
78
with DrugDomain annotations
7.0% of members
51
with a DrugBank compound
4.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2004.1.1.45 belongs to X-group 2004 P-loop domains-like, which binds 7.5 ligand superclasses per 20 proteins, narrower than 53% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB16833 | ADP | Adenosine disphosphate | 45 |
| DB00171 | ATP | ATP | 6 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ADP | ADENOSINE-5'-DIPHOSPHATE | 60 |
| MGmetal | MAGNESIUM ION | 52 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 24 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 12 |
| CL | CHLORIDE ION | 7 |
| AGS | PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER | 4 |
| NAmetal | SODIUM ION | 4 |
| YKQ | Abivertinib | 4 |
| YKW | ~{N}-(4-chlorophenyl)-2-(4-ethylpiperazin-1-yl)pteridin-4-amine | 3 |
| BEF | BERYLLIUM TRIFLUORIDE ION | 2 |
| VO4 | VANADATE ION | 2 |